- Home
- PHAT vs CURV Comparison
PHAT vs CURV Comparison
Compare PHAT & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- CURV
- Stock Information
- Founded
- PHAT 2018
- CURV 2001
- Country
- PHAT United States
- CURV United States
- Employees
- PHAT N/A
- CURV N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- CURV Clothing/Shoe/Accessory Stores
- Sector
- PHAT Health Care
- CURV Consumer Discretionary
- Exchange
- PHAT Nasdaq
- CURV Nasdaq
- Market Cap
- PHAT 465.0M
- CURV 402.0M
- IPO Year
- PHAT 2019
- CURV 2021
- Fundamental
- Price
- PHAT $6.96
- CURV $6.29
- Analyst Decision
- PHAT Strong Buy
- CURV Hold
- Analyst Count
- PHAT 4
- CURV 5
- Target Price
- PHAT $23.00
- CURV $5.25
- AVG Volume (30 Days)
- PHAT 971.9K
- CURV 424.5K
- Earning Date
- PHAT 03-06-2025
- CURV 12-03-2024
- Dividend Yield
- PHAT N/A
- CURV N/A
- EPS Growth
- PHAT N/A
- CURV 29.45
- EPS
- PHAT N/A
- CURV 0.14
- Revenue
- PHAT $26,270,000.00
- CURV $1,121,714,000.00
- Revenue This Year
- PHAT $7,622.43
- CURV N/A
- Revenue Next Year
- PHAT $236.87
- CURV N/A
- P/E Ratio
- PHAT N/A
- CURV $44.47
- Revenue Growth
- PHAT N/A
- CURV N/A
- 52 Week Low
- PHAT $6.07
- CURV $2.18
- 52 Week High
- PHAT $19.71
- CURV $9.14
- Technical
- Relative Strength Index (RSI)
- PHAT 37.02
- CURV 76.08
- Support Level
- PHAT $6.36
- CURV $5.46
- Resistance Level
- PHAT $7.20
- CURV $6.00
- Average True Range (ATR)
- PHAT 0.48
- CURV 0.37
- MACD
- PHAT 0.08
- CURV 0.04
- Stochastic Oscillator
- PHAT 30.48
- CURV 100.00
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America targeting 27 to 42-year-old women. It is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of e-Commerce platform and stores.